Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04262609 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Faecal Incontinence in Prostate Cancer Survivors Treated Whith Radiotherapy

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Sep 8, 2023 to Feb 1, 2026
    • Study completion date: Dec 1, 2025 to Dec 1, 2026
    v8
  2. Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Dec 1, 2023 to Dec 1, 2025
    • Site details revised
    v7
  3. Primary completion date changed from estimate of May 2023 to Sep 8, 2023
    • Study completion date: Dec 2023 to Dec 1, 2023
    v6
  4. Primary completion date: Jul 2022 to May 2023
    • Study completion date: Jul 2022 to Dec 2023
    • Start date changed from estimate of Jul 2022 to Jul 1, 2019
    v5
  5. Start date: Feb 2022 to Jul 2022
    • Primary and study completion dates: Feb 2022 to Jul 2022
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting
    • Primary completion date: Feb 2021 to Feb 2022
    • Start date: Feb 2021 to Feb 2022
    • Site details revised
    v3
  2. Start date: Feb 2020 to Feb 2021
    • Site contact updated
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of the study is to determine the incidence of faecal incontinence in prostate cancer survivors treated with moderately hypofractionated radiation therapy and correlate the dose received by the anal sphincter with the degree of faecal incontinence.
Trial Details
NCT Number NCT04262609
Lead Sponsor Consorci Sanitari de Terrassa
Conditions
(from sponsor)		 Faecal Incontinence, Prostate Cancer
Related terms Encopresis, Prostatic Neoplasms
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov